Your browser doesn't support javascript.
loading
Protein Intake, IGF-1 Concentrations, and Growth in the Second Year of Life in Children Receiving Growing Up Milk - Lite (GUMLi) or Cow's Milk (CM) Intervention.
Lovell, Amy L; Milne, Tania; Matsuyama, Misa; Hill, Rebecca J; Davies, Peter S W; Grant, Cameron C; Wall, Clare R.
Afiliação
  • Lovell AL; Department of Nutrition and Dietetics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Milne T; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Matsuyama M; Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia.
  • Hill RJ; Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia.
  • Davies PSW; Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia.
  • Grant CC; Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand.
  • Wall CR; Centre for Longitudinal Research He Ara ki Mua, University of Auckland, Auckland, New Zealand.
Front Nutr ; 8: 666228, 2021.
Article em En | MEDLINE | ID: mdl-34179057
ABSTRACT
The relationship of protein intake with insulin-like growth factor 1 (IGF-1) concentrations in well-nourished children during the second year of life is poorly understood. The aim of this study was to explore the effect of a reduced-protein Growing Up Milk Lite (GUMLi) or unfortified cow's milk (CM) on protein intake, growth, and plasma IGF-1 at 2 y. An exploratory analysis of a sub-sample of Auckland-based children (n = 79) in the GUMLi trial (a double-blind, randomised control trial, N = 160) completed in Auckland and Brisbane (2015-2017) was conducted. One-year old children were randomised to receive a reduced-protein GUMLi (1.7 g protein/100 mL) or a non-fortified CM (3.1 g protein/100 mL) for 12 months. Blood sampling and anthropometric measurements were made at 1 and 2 y. Diet was assessed using a validated food frequency questionnaire. Total protein intake (g/d) from all cow's milk sources was 4.6 g (95% CI -6.7, -2.4; p < 0.005) lower in the GUMLi group after 12 months of the intervention, with a significant group-by-time interaction (p = 0.005). Length-for-age (LAZ) and weight-for-length (WLZ) z-scores did not differ between groups, however, mean body fat % (BF%) was 3.2% (95%CI -6.2, -0.3; p = 0.032) lower in the GUMLi group at 2 y. There was no difference between the intervention groups in relation to IGF-1 and IGF-BP3 (p = 0.894 and 0.698, respectively), with no group-by-sex interaction. After combining the groups, IGF-1 concentration at 2 y was positively correlated with parameters of growth (all p < 0.05), total cow's milk intake (p = 0.032) after adjusting for sex, breastfeeding status, and gestation. Randomisation to a reduced protein GUMLi resulted in small reduction in %BF and lower total protein intakes but had no effect on growth. Plasma IGF-1 concentrations were independently associated with total protein intake from cow's milk at 2 y, highlighting a potential area of the diet to target when designing future protein-related nutrition interventions. Clinical Trial Registration Australian New Zealand Clinical Trials Registry number ACTRN12614000918628. Date registered 27/08/2014.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Nutr Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Nutr Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Nova Zelândia